ConcertAI, a leading oncology real-world evidence data and AI SaaS technology company, and Foundation Medicine, a global, ...

BOSTON & EL MONTE, Calif.--(BUSINESS WIRE)-- Foundation Medicine, Inc., a genomics company committed to transforming cancer care, today announced plans to launch two new germline tests, ...

Findings Published in Nature Medicine Highlight Clinical Application of Next-Generation Sequencing to Suggest Targeted Therapeutic Options for Patients CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation ...

BOSTON--(BUSINESS WIRE)--Foundation Medicine, Inc. today announced it was awarded its second consecutive, five-year contract by the U.S. Department of Veterans Affairs (VA) to provide tumor molecular ...

BOSTON--(BUSINESS WIRE)--Foundation Medicine, Inc., a genomics company committed to transforming cancer care, today announced that it has expanded its immunohistochemistry (IHC) test offerings to ...

BOSTON--(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced a collaboration with Syndax Pharmaceuticals (Nasdaq: SNDX) to develop a companion diagnostic for the identification of acute myeloid ...

Boca Raton, Fla.-based Cancer Treatment Centers of America and Foundation Medicine are collaborating on an educational campaign to raise awareness regarding the potential of precision medicine.